Patent Assignment
Reel/Frame 063942/0664
Partial Release of Security Interest
Recorded: 2023-06-09
Pages: 9
Assignor
HERCULES CAPITAL, INC.
Executed: 2023-06-08
Assignee
IVERIC BIO, INC.
8 SYLVAN WAY, PARSIPPANY, NEW JERSEY, 07054
Covered Properties
(5)
Gene Therapies for Stargardt Disease (ABCA4)
PCT:
PCT/US2022/026172 ↗
Minigene Therapy
Gene Therapies for Usher Syndrome (USH2A)
Application:
17/604,545 →
Publication:
US 2022/0202959
Gene Therapies for Stargardt Disease (ABCA4)
Minigene Therapy
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 15, 2019
From: GAO, GUANGPING; KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 051015/0787 →
Assignment of Assignor's Interest
Mar 15, 2022
From: KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 059262/0761 →
Assignment of Assignor's Interest
Mar 15, 2022
From: KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 059262/0857 →
Assignment of Assignor's Interest
Mar 15, 2022
From: GAO, GUANGPING; KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 059262/0927 →
Security Interest
Aug 5, 2022
From: IVERIC BIO, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 061088/0048 →
Assignment of Assignor's Interest
Oct 14, 2022
From: KHANNA, HEMANT
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 061421/0235 →
Release of Security Interest
Jul 17, 2023
From: HERCULES CAPITAL, INC.
To: IVERIC BIO, INC.; IVERIC BIO GENE THERAPY LLC; ORION OPHTHALMOLOGY LLC
Reel/Frame 064286/0472 →